Faculty profile

Christopher Booth

ResearcherOncologyQueen's University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Queen's University directory, so their courses and email address may be missing. Find their university profile.

Christopher Booth

Researcher

Oncology

Health Sciences

Queen's University

Kingston, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
26 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 5 research grants (5 CIHR), most recently in 2018.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Crc Chemotherapy Colon Cancer Health Services Research Outcomes Patterns Of Care Quality Of Care Surgery

Latest papers

When the System Is the Treatment: Rethinking Nonpharmacologic Breakthroughs in Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026 · senior author
Quality of life following completion of surgery and chemoradiation among Sri Lankan women with breast cancer.
BMC cancer · 2026
Returning to Work After Cancer Treatment: An Exploratory Sequential Mixed-Methods Study Guided by Transitions Theory.
Cancer nursing · 2026

All 43 publications

Latest funding

Bridging a gap in global oncology research: Building capacity in research methods in Rwanda.
CIHR · 2023 · Co-investigator
$19,870
Randomized controlled trial of in-person and virtual Symptom screening with Targeted Early Palliative care (STEP2) in patients with advanced cancer
CIHR · 2023 · Co-investigator
$929,475
Real-World Outcomes Associated with PARP Inhibitor Maintenance Therapy in Ovarian Cancer: A Population-Based Study
CIHR · 2022 · Co-investigator
$100,000

All 19 grants and awards

43 publications.

When the System Is the Treatment: Rethinking Nonpharmacologic Breakthroughs in Oncology.

Sedhom R, Dotan E, Booth C

Journal of clinical oncology : official journal of the American Society of Clinical Oncology2026Senior author

DOI: 10.1200/jco-25-02664 PMID: 41632513

Quality of life following completion of surgery and chemoradiation among Sri Lankan women with breast cancer.

Wijayalathge H, Peiris K, Jayarajah U, Gunasekara S, Wijeratne DT, Booth C, Seneviratne S

BMC cancer2026

DOI: 10.1186/s12885-026-15991-7 PMID: 41975345

Returning to Work After Cancer Treatment: An Exploratory Sequential Mixed-Methods Study Guided by Transitions Theory.

Galica J, Alsius A, Walker L, Stark D, Noor H, Kain D, Booth C, Wickenden A

Cancer nursing2026

DOI: 10.1097/ncc.0000000000001449 PMID: 39778099

How Important is Healthcare-Contact Time to Systemic Treatment Decision-Making in Advanced Gastrointestinal Cancers: Developing Attributes to Include in a Discrete Choice Experiment.

Stevens SX, El-Katateny E, Addo IY, Street D, Booth C, Shaw J, Vardy JL, De Abreu Lourenco R

The patient2026

DOI: 10.1007/s40271-025-00778-y PMID: 41182661

Stress, Resilience, Moral Distress, and Depression-Anxiety Among Oncology Care Providers in Colombia During the COVID-19 Pandemic.

Martinez N, García MDP, Hanna TP, Soares CN, Uribe M, Sullivan R, Booth C, Murillo R

Revista Colombiana de psiquiatria2025

DOI: 10.1016/j.rcpeng.2025.10.004 PMID: 41241460

Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials: A Meta-Epidemiological Analysis.

Sherry AD, Miller AM, Parlapalli JP, Kupferman GS, Beck EJ, McDonald J, Kouzy R, Abi Jaoude J, Lin TA, Sanford NN, Chino F, Gyawali B, Booth C, Msaouel P, Ludmir EB

JAMA oncology2025

DOI: 10.1001/jamaoncol.2025.1002 PMID: 40451185

Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop.

Pe M, Voltz-Girolt C, Bell J, Bhatnagar V, Bogaerts J, Booth C, Burgos JG, Cappelleri JC, Coens C, Demolis P, Enzmann H, Giesinger JM, Gilbert A, Groenvold M, Kluetz P, Piccinin C, Postmus D, Quinten C, Ryll B, Sasseville M, Schlichting M, Schuerer H, Schiel A, Shaw JW, Smith AW, Tezuka S, Torre C, van der Graaf WTA, Wieseler B, Wittenbecher F, Reijneveld JC, Mol P

The Lancet. Oncology2025

DOI: 10.1016/s1470-2045(25)00150-0 PMID: 40245904

Congruence of cancer screening recommendations between the USPSTF and the top ten US cancer centers: a cross sectional study.

Wright K, Shkabari B, Booth C, Knopf K, Tregear M, Gyawali B

EClinicalMedicine2025

DOI: 10.1016/j.eclinm.2025.103169 PMID: 40235947

Consuming Patients' Days: Time Spent on Ambulatory Appointments by People With Cancer.

Kagalwalla S, Tsai AK, George M, Waldock A, Davis S, Jewett P, Vogel RI, Ganguli I, Booth C, Dusetzina SB, Rocque GB, Blaes AH, Gupta A

The oncologist2024

DOI: 10.1093/oncolo/oyae016 PMID: 38339991

Unification of Efforts to Improve Global Access to Cancer Therapeutics: Report From the 2022/2023 Access to Essential Cancer Medicines Stakeholder Summit.

Briercheck E, Pyle D, Adams C, Atun R, Booth C, Dent J, Garcia-Gonzalez P, Ilbawi A, Jazieh AR, Kerr D, Knaul F, Kobayashi E, Lim C, Maza M, Milner D, Navarro MF, O'Brien M, Rodriguez-Galindo C, Sullivan R, Torode J, Vokes E, Gralow J

JCO global oncology2024

DOI: 10.1200/go.23.00256 PMID: 38781548

Something wrong or missing on this profile? Suggest a correction

Christopher Booth

Research

Latest papers

Latest funding

When the System Is the Treatment: Rethinking Nonpharmacologic Breakthroughs in Oncology.

Quality of life following completion of surgery and chemoradiation among Sri Lankan women with breast cancer.

Returning to Work After Cancer Treatment: An Exploratory Sequential Mixed-Methods Study Guided by Transitions Theory.

How Important is Healthcare-Contact Time to Systemic Treatment Decision-Making in Advanced Gastrointestinal Cancers: Developing Attributes to Include in a Discrete Choice Experiment.

Stress, Resilience, Moral Distress, and Depression-Anxiety Among Oncology Care Providers in Colombia During the COVID-19 Pandemic.

Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials: A Meta-Epidemiological Analysis.

Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop.

Congruence of cancer screening recommendations between the USPSTF and the top ten US cancer centers: a cross sectional study.

Consuming Patients' Days: Time Spent on Ambulatory Appointments by People With Cancer.

Unification of Efforts to Improve Global Access to Cancer Therapeutics: Report From the 2022/2023 Access to Essential Cancer Medicines Stakeholder Summit.

Using Transitions Theory to examine approaches for individuals who are returning to work

Frequent collaborators

Michael Brundage

Jacqueline Galica

Fidel Rubagumya

Michael Ong

Gregory Pond

Dean Fergusson

Melanie Jaeger

Mark Clemons

Kednapa Thavorn

Elena Elimova

Danielle Rodin

Eitan Amir

Meredith Giuliani

Christina Canil

John Hilton

Mary Gospodarowicz

Sumit Gupta

Igor Karp

Kednapa Thavorn

Andrew Robinson

Sunil Patel

Ophira Ginsburg

Geoffrey Liu

Brian Hutton

Zeev Rosberger